Disease Markers

Table of Contents

  • Disease Markers -
  • Special Issue
  • Volume 21
  • - Article ID 340186

CYP1A1 Genetic Polymorphisms in Ecuador, South America

César Paz-y-Miño | Melissa Arévalo | ... | Paola. E. Leone
  • Disease Markers -
  • Special Issue
  • Volume 31
  • - Article ID 757840

Circulating Endothelial Cells in Patients with Heart Failure and Left Ventricular Dysfunction

Vicenta Martínez-Sales | Ignacio Sánchez-Lázaro | ... | Edelmiro Reganon
  • Disease Markers -
  • Special Issue
  • Volume 33
  • - Article ID 540597

Serum Homocysteine, Vitamin B12, Folic Acid Levels and Methylenetetrahydrofolate Reductase (MTHFR) Gene Polymorphism in Vitiligo

Ali Yasar | Kamer Gunduz | ... | Mehmet Calkan
  • Disease Markers -
  • Special Issue
  • Volume 15
  • - Article ID 183537
  • - Abstract

Current Policies for Surveillance and Management in Women at Risk for Breast and Ovarian Cancer: A Survey among 16 European Family Cancer Clinics

H. F. A. Vasen | N. E. Haites | ... | European Familial Breast Cancer Collaborative Group
  • Disease Markers -
  • Special Issue
  • Volume 32
  • - Article ID 675628

GSTT1 Null Genotype Is a Risk Factor for Diabetic Retinopathy in Caucasians with Type 2 Diabetes, whereas GSTM1 Null Genotype Might Confer Protection against Retinopathy

Ines Cilenšek | Sara Mankoč | ... | Daniel Petrovič
  • Disease Markers -
  • Special Issue
  • Volume 27
  • - Article ID 267581

Molecular Profiling of Glatiramer Acetate Early Treatment Effects in Multiple Sclerosis

Anat Achiron | Anna Feldman | Michael Gurevich
  • Disease Markers -
  • Special Issue
  • - Volume 19
  • - Article ID 460797

The Role of Diffuse Optical Spectroscopy in the Clinical Management of Breast Cancer

Natasha Shah | Albert E. Cerussi | ... | Bruce J. Tromberg
  • Disease Markers -
  • Special Issue
  • Volume 13
  • - Article ID 842051

Detection of the Low Density Lipoprotein Receptor Gene Pvuii Intron 15 Polymorphism Using the Polymerase Chain Reaction: Association With Plasma Lipid Traits in Healthy Men and Women

V. Gudnason | T. Zhou | ... | H. Schuster
  • Disease Markers -
  • Special Issue
  • - Volume 30
  • - Article ID 928497

Corticotrophin-Releasing Hormone Type 1 Receptor Gene (CRHR1) Variants Predict Posttraumatic Stress Disorder Onset and Course in Pediatric Injury Patients

Ananda B. Amstadter | Nicole R. Nugent | ... | Karestan C. Koenen
  • Disease Markers -
  • Special Issue
  • Volume 14
  • - Article ID 861096

The Genetics of Signal Transduction and the Feto-Maternal Relationship. A Study of Cytosolic Low Molecular Weight Phosphotyrosine Phosphatase

E. Bottini | E. Cosmi | ... | N. Lucarini
  • Disease Markers -
  • Special Issue
  • Volume 11
  • - Article ID 682804

Luminoimmunometric Assay of Tissue Polypeptide Antigen (Tpa) and Cancer Antigen 125 (Ca-125) in Breast Cancer Patients

O. El-Ahmady | Halim A.-B. | S. Eissa
  • Disease Markers -
  • Special Issue
  • Volume 22
  • - Article ID 321798

Non Classical HLA Genes and Non-HLA Genes in a Population of Infants at Familial Risk of Atopy

A. De Silvestri | C. Belloni | ... | M. Cuccia
  • Disease Markers -
  • Special Issue
  • Volume 28
  • - Article ID 396328

Expression of MicroRNAs in the Urinary Sediment of Patients with IgA Nephropathy

Gang Wang | Bonnie Ching-Ha Kwan | ... | Cheuk-Chun Szeto
  • Disease Markers -
  • Special Issue
  • Volume 34
  • - Article ID 795410

Mutational Spectrum of Gelsolin and Its Down Regulation Is Associated with Breast Cancer

Ruqia Mehmood Baig | Ishrat Mahjabeen | ... | Mahmood Akhtar Kayani
  • Disease Markers -
  • Special Issue
  • Volume 29
  • - Article ID 816149

GSTT1 as a Prognosticator for Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer

Yun-Sok Ha | Chunri Yan | ... | Wun-Jae Kim
Disease Markers
 Journal metrics
See full report
Acceptance rate6%
Submission to final decision131 days
Acceptance to publication42 days
CiteScore3.700
Journal Citation Indicator-
Impact Factor-

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.